Kura Oncology, Inc. (KURA)
11.39
-0.18
(-1.56%)
USD |
NASDAQ |
Sep 11, 16:00
11.30
-0.09
(-0.79%)
After-Hours: 06:09
Kura Oncology Market Cap : 1.013B for Sept. 11, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 11, 2026 | 1.013B |
| September 10, 2026 | 1.029B |
| September 09, 2026 | 1.075B |
| September 08, 2026 | 1.114B |
| September 04, 2026 | 1.179B |
| September 03, 2026 | 1.170B |
| September 02, 2026 | 1.166B |
| September 01, 2026 | 1.147B |
| August 31, 2026 | 1.125B |
| August 28, 2026 | 1.126B |
| August 27, 2026 | 1.172B |
| August 26, 2026 | 1.162B |
| August 25, 2026 | 1.209B |
| August 24, 2026 | 1.103B |
| August 21, 2026 | 1.058B |
| August 20, 2026 | 1.042B |
| August 19, 2026 | 1.115B |
| August 18, 2026 | 1.097B |
| August 17, 2026 | 1.003B |
| August 14, 2026 | 966.04M |
| August 13, 2026 | 897.55M |
| August 12, 2026 | 884.20M |
| August 11, 2026 | 883.31M |
| August 10, 2026 | 876.20M |
| August 07, 2026 | 849.46M |
| Date | Value |
|---|---|
| August 06, 2026 | 823.72M |
| August 05, 2026 | 816.62M |
| August 04, 2026 | 840.59M |
| August 03, 2026 | 815.73M |
| July 31, 2026 | 799.75M |
| July 30, 2026 | 826.38M |
| July 29, 2026 | 792.65M |
| July 28, 2026 | 826.38M |
| July 27, 2026 | 900.94M |
| July 24, 2026 | 922.25M |
| July 23, 2026 | 927.57M |
| July 22, 2026 | 935.56M |
| July 21, 2026 | 966.63M |
| July 20, 2026 | 947.99M |
| July 17, 2026 | 963.97M |
| July 16, 2026 | 966.63M |
| July 15, 2026 | 1.006B |
| July 14, 2026 | 997.70M |
| July 13, 2026 | 968.40M |
| July 10, 2026 | 1.016B |
| July 09, 2026 | 1.072B |
| July 08, 2026 | 1.076B |
| July 07, 2026 | 1.064B |
| July 06, 2026 | 979.94M |
| July 02, 2026 | 985.27M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Inovio Pharmaceuticals, Inc. | 102.93M |
| Fortress Biotech, Inc. | 83.94M |
| Syndax Pharmaceuticals, Inc. | 1.621B |
| Spero Therapeutics, Inc. | 65.71M |
| Gossamer Bio, Inc. | 5.245B |
Market Cap Related Metrics
| PS Ratio | 13.02 |
| PEG Ratio | -0.0693 |
| Price to Book Value | 20.92 |
| Price | 11.39 |
| Earnings Yield | -29.52% |
| PEGY Ratio | -0.0693 |